- Home
- DNP vs PRGO Comparison
DNP vs PRGO Comparison
Compare DNP & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNP
- PRGO
- Stock Information
- Founded
- DNP 1986
- PRGO 1887
- Country
- DNP United States
- PRGO Ireland
- Employees
- DNP N/A
- PRGO N/A
- Industry
- DNP Investment Managers
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- DNP Finance
- PRGO Health Care
- Exchange
- DNP Nasdaq
- PRGO Nasdaq
- Market Cap
- DNP 3.4B
- PRGO 3.5B
- IPO Year
- DNP N/A
- PRGO 1991
- Fundamental
- Price
- DNP $9.01
- PRGO $25.76
- Analyst Decision
- DNP
- PRGO Buy
- Analyst Count
- DNP 0
- PRGO 4
- Target Price
- DNP N/A
- PRGO $37.00
- AVG Volume (30 Days)
- DNP 708.8K
- PRGO 1.3M
- Earning Date
- DNP 01-01-0001
- PRGO 11-06-2024
- Dividend Yield
- DNP 8.63%
- PRGO 4.29%
- EPS Growth
- DNP N/A
- PRGO N/A
- EPS
- DNP N/A
- PRGO N/A
- Revenue
- DNP N/A
- PRGO $4,392,000,000.00
- Revenue This Year
- DNP N/A
- PRGO N/A
- Revenue Next Year
- DNP N/A
- PRGO $4.51
- P/E Ratio
- DNP N/A
- PRGO N/A
- Revenue Growth
- DNP N/A
- PRGO N/A
- 52 Week Low
- DNP $8.09
- PRGO $23.89
- 52 Week High
- DNP $11.18
- PRGO $34.60
- Technical
- Relative Strength Index (RSI)
- DNP 36.92
- PRGO 36.42
- Support Level
- DNP $8.75
- PRGO $25.16
- Resistance Level
- DNP $9.60
- PRGO $28.62
- Average True Range (ATR)
- DNP 0.16
- PRGO 0.66
- MACD
- DNP -0.06
- PRGO -0.35
- Stochastic Oscillator
- DNP 30.58
- PRGO 15.79
About DNP DNP Select Income Fund Inc.
DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.